Behind the Mystery
A specialized, recurring segment devoted to rare and genetic diseases, Behind The Mystery highlights the emotional, scientific, and medical aspects associated with rare and genetic diseases. We clarify the often-complex issues by offering easy-to-understand explanations from top experts in the field. Our goal is to expand awareness for rare and genetic diseases through partnerships with pharmaceutical and biotech companies while giving voices to the patients, families, and advocates affected via our national television platform.
We're going Behind the Mystery of Sarcoidosis, learning about Calibrate, and more.
Sarcoidosis is an inflammatory disease that can affect almost any organ in the body, but most commonly targets the lungs and lymph nodes. Due to the high unmet medical need for patients with advanced or chronic forms of the condition, there is an urgency for effective and accessible treatment options.
LGS is a rare neurodevelopmental disorder that evolves over time in very young children from treatment-resistant seizures.
The EB Research Partnership is the largest global organization dedicated to funding research to treat and cure Epidermolysis Bullosa or EB.
Primary HLH is a rare, rapidly progressive, and fatal disorder with a median survival of less than 2 months.
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.
We're going Behind the Mystery of two rare diseases: Castleman disease and chondrosarcoma.
Systemic Mastocytosis (SM) is characterized by the overactivity and build-up of mast cells throughout the body. Learn more now.